Pulse Biosciences (PLSE) Cash from Investing Activities (2020 - 2025)

Pulse Biosciences has reported Cash from Investing Activities over the past 6 years, most recently at -$105000.0 for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$105000.0 for Q4 2025, down 98.11% from a year ago — trailing twelve months through Dec 2025 was -$335000.0 (down 168.0% YoY), and the annual figure for FY2025 was -$335000.0, down 168.0%.
  • Cash from Investing Activities for Q4 2025 was -$105000.0 at Pulse Biosciences, down from -$62000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for PLSE hit a ceiling of $7.9 million in Q1 2021 and a floor of -$279000.0 in Q1 2022.
  • Median Cash from Investing Activities over the past 5 years was -$44000.0 (2023), compared with a mean of $329050.0.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 99.3% in 2021 and later plummeted 800.0% in 2025.
  • Pulse Biosciences' Cash from Investing Activities stood at -$134000.0 in 2021, then skyrocketed by 69.4% to -$41000.0 in 2022, then dropped by 4.88% to -$43000.0 in 2023, then fell by 23.26% to -$53000.0 in 2024, then tumbled by 98.11% to -$105000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$105000.0 (Q4 2025), -$62000.0 (Q3 2025), and -$123000.0 (Q2 2025) per Business Quant data.